Literature DB >> 17385998

Reducing aversion to side effects in preventive medical treatment decisions.

Erika A Waters1, Neil D Weinstein, Graham A Colditz, Karen M Emmons.   

Abstract

Laypeople tend to be overly sensitive to side effects of treatments that prevent illness, possibly leading them to refuse beneficial therapies. This Internet-based study attempted to reduce such side effect aversion by adding graphic displays to the numerical risk probabilities. It also explored whether graphics reduce side effect aversion by making it easier for respondents to determine how the treatment might change their net cancer risk. Participants (N=4,248) were presented with a hypothetical preventive treatment situation that was or was not accompanied by a small side effect. In both conditions, the net absolute risk reduction was 12%. Adding an array of stick figures to risk probabilities reduced side effect aversion substantially, but adding a bar graph was not beneficial. The ability of arrays to reduce side effect aversion was not attributable to greater accuracy in evaluating the treatment's net benefit. ((c) 2007 APA, all rights reserved).

Entities:  

Mesh:

Year:  2007        PMID: 17385998     DOI: 10.1037/1076-898X.13.1.11

Source DB:  PubMed          Journal:  J Exp Psychol Appl        ISSN: 1076-898X


  29 in total

1.  Beneficent persuasion: techniques and ethical guidelines to improve patients' decisions.

Authors:  J S Swindell; Amy L McGuire; Scott D Halpern
Journal:  Ann Fam Med       Date:  2010 May-Jun       Impact factor: 5.166

2.  Affective forecasting and medication decision making in breast-cancer prevention.

Authors:  Michael Hoerger; Laura D Scherer; Angela Fagerlin
Journal:  Health Psychol       Date:  2016-02-11       Impact factor: 4.267

3.  Spontaneous mental associations with the words "side effect": Implications for informed and shared decision making.

Authors:  Sonya Izadi; Thorsten Pachur; Courtney Wheeler; Jaclyn McGuire; Erika A Waters
Journal:  Patient Educ Couns       Date:  2017-05-24

4.  Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.

Authors:  Erika A Waters; Timothy S McNeel; Worta McCaskill Stevens; Andrew N Freedman
Journal:  Breast Cancer Res Treat       Date:  2012-05-24       Impact factor: 4.872

5.  Using the Short Graph Literacy Scale to Predict Precursors of Health Behavior Change.

Authors:  Yasmina Okan; Eva Janssen; Mirta Galesic; Erika A Waters
Journal:  Med Decis Making       Date:  2019-03-08       Impact factor: 2.583

6.  Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.

Authors:  Jennifer G McIntosh; Jesse Minshall; Sibel Saya; Adrian Bickerstaffe; Nadira Hewabandu; Ashleigh Qama; Jon D Emery
Journal:  Br J Gen Pract       Date:  2019-11-28       Impact factor: 5.386

7.  Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.

Authors:  Erika A Waters; Kathleen A Cronin; Barry I Graubard; Paul K Han; Andrew N Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

8.  How to reduce the effect of framing on messages about health.

Authors:  Rocio Garcia-Retamero; Mirta Galesic
Journal:  J Gen Intern Med       Date:  2010-08-25       Impact factor: 5.128

9.  Explanations for side effect aversion in preventive medical treatment decisions.

Authors:  Erika A Waters; Neil D Weinstein; Graham A Colditz; Karen Emmons
Journal:  Health Psychol       Date:  2009-03       Impact factor: 4.267

10.  What is my cancer risk? How internet-based cancer risk assessment tools communicate individualized risk estimates to the public: content analysis.

Authors:  Erika A Waters; Helen W Sullivan; Wendy Nelson; Bradford W Hesse
Journal:  J Med Internet Res       Date:  2009-07-31       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.